Press release: Ncardia and Cellistic appoint Jason Conner as new CEO

Published on March 10, 2026
Press release: Ncardia and Cellistic appoint Jason Conner as new CEO

MONT-SAINT-GUIBERT, Belgium & LEIDEN, Netherlands – March [9], 2026 – Cellistic, a global leader in allogeneic iPSC-derived cell therapy manufacturing and development services, today announced that Jason Conner has been appointed Chief Executive Officer, effective immediately. Mr. Conner will also serve in the same capacity for Cellistic’s sister business, Ncardia, a leader in stem cell–based solutions for drug discovery and safety assessment. He has served on the Board of Directors since 2022.

Continue reading on website
Other news

Where Documentation Time is Really Going in EMS & Fire: The Time Sinks That Crews Expect | Part 1 of 3

March 9, 2026
If you’ve ever worked a shift in EMS or fire service, you know how documentation goes: you navigate chaos on the scene, provide life-saving care, and then sit down to document every detail of the call in what feels like an endless stream of clicks, drop-downs, and double-checks.   Why does EMS and fire documentation take so long? Ask most crews, and they’ll point […]The post Where Documentation Ti

What Community Health Software Looks Like in Action

March 10, 2026
Community paramedicine and mobile integrated healthcare (MIH) programs do a lot of work that traditional 911 documentation was never designed to capture. It’s not just one incident. It’s the phone call two days later, the follow-up visit, the medication adjustment, the benefits paperwork—all the in-between touches that actually move the needle for a patient over […]The post What Community Health S